/Physician Resources

The MBC Project

By | May 22nd, 2016|

The IBC Network Foundation honored to be a partner with the Metastatic Breast Cancer Project. The [...]

IBC And Brain Metastases

By | October 28th, 2015|

IBC metastasizes to the brain in about 19% of IBC patients within the first 2 [...]

Research Update From Balko, Schwarz, Arteaga

By | October 2nd, 2015|

Triple negative breast cancers with amplification of JAK2 at the 9p24 loci demonstrate JAK2-specific dependence. [...]

IBC Treatment Flow Chart

By | September 7th, 2015|

The MD Anderson Invasive Breast Cancer Treatment Algorithm has been updated to include inflammatory breast [...]

Bone-only Metastasis in IBC and non-IBC Patients

By | September 12th, 2014|

An interesting article is included below regarding bone-only metastasis in inflammatory and non-inflammatory breast cancer patients. The Clinical Breast [...]

Roswell Park Led Team Identifies Mechanism of Chemotherapy Resistance in Inflammatory Breast Cancer

By | July 7th, 2014|

Specific cancer stem cells need to be treated in a different manner than the whole [...]

International Conference in Belgium

By | June 24th, 2014|

The 4th International Inflammatory Breast Cancer Conference was held in May of 2014 in Belgium.  [...]

Cancer Drug Priced Too High

By | April 24th, 2014|

Two days ago, an article was posted on BBC  News Website by Michelle Roberts the Health editor [...]

The Cancer Geek

By | April 3rd, 2014|

Dr. Angela Alexander posted this April 1st to her personal blog, "The Cancer Geek", which [...]

Molecular Profiling of the Residual Disease of Triple-Negative Breast Cancers

By | March 14th, 2014|

Molecular Profiling of the Residual Disease of Triple-Negative Breast Cancers after Neoadjuvant Chemotherapy, Identifies Actionable [...]

IBC Presents Grant for Brain Metastasis

By | February 26th, 2014|

On Thursday, February 27, 2014 at 9:30 am, The IBC Network Foundation will present a [...]

Congratulations to Dr. Anfossi and Dr. Reuben

By | January 10th, 2014|

Congratulations to Dr. Anfossi and Dr. Reuben. The new paper entitled "High Serum miR-19a Levels [...]

SABCS13 Highlights by Dr. Robert Miller

By | December 20th, 2013|

Dr. Robert Miller Dr. Robert Miller is an oncologist at John Hopkins University [...]

Inhibition of PARP

By | December 17th, 2013|

Interesting... When a healthy cell is damaged, there are two paths it can take. The [...]

IBC Track At SABCS13 Has Lead To News Coverage

By | December 12th, 2013|

Dr Wendy Woodward & Kathy LaTour Dr Wendy Woodward, a radiation oncologist and [...]

The Third International Inflammatory Breast Cancer Conference

By | December 11th, 2013|

With the 2013 San Antonio Breast Cancer Symposium going on December 10th - 14th that [...]

Open-Label, Single-Arm Phase 2 Study

By | December 11th, 2013|

During October 23, 2008 and October 28, 2009 the Institut Curie, Paris, France conducted an open-label, [...]

IBC Education Included at the 2013 San Antonio Breast Cancer Symposium

By | December 9th, 2013|

The 2013 San Antonio Breast Cancer Symposium is presented by the Cancer Therapy & Research [...]

Comparison of molecular subtype distribution in triple negative inflammatory and non inflammatory breast cancers

By | December 8th, 2013|

Inflammatory Breast Cancer, otherwise known as IBC, has a very poor prognosis due to its [...]

Pink+

By | December 3rd, 2013|

The IBC Network is honored to share this guest post from  Oliver Bogler, Ph.D. He [...]

Statin and Inflammatory Breast Cancer

By | December 1st, 2013|

The following is an introduction written by Dr. Ueno director of the Morgan Welch Clinic [...]

European regulator clears Roche’s Kadcyla for advanced breast cancer

By | November 24th, 2013|

Kadcyla but was known as T-DM1 is called the new Herceptin, giving hope to [...]

The Death of Research As We Know It?

By | September 29th, 2013|

The following article was published in Breast Investigators in January of 2013.  However, I wanted [...]

Triple Negative Breast Cancer: From Bench to Clinic in 2013

By | September 22nd, 2013|

A guest post by Dr Angela Alexander, a TRIUMPH translational postdoctoral fellow at MD Anderson. [...]

Cancer Progress Report 13

By | September 18th, 2013|

Kim Alexander shares her story in the American Association of Cancer Research (AACR) Cancer Progress [...]

18F-FDG PET/CT predicts survival in patients with Inflammatory Breast Cancer undergoing neoadjuvant chemotherapy

By | September 4th, 2013|

In August 2013 Dr Uneo of the Morgan Welch Inflammatory Breast Cancer Research Program and [...]

Inflammatory Breast Cancer: What We Know and What We Need to Learn

By | September 3rd, 2013|

Simply titled, Inflammatory Breast Cancer: What We Know and What We Need to Learn, is [...]

Differential Response to Neoadjuvant Chemotherapy

By | August 15th, 2013|

2013 Aug 15. [Epub ahead of print] Masuda H, Baggerly KA, Wang Y, Zhang Y, [...]

Diagnosing Inflammatory Breast Cancer can be Difficult

By | August 11th, 2013|

Diagnosing Inflammatory Breast Cancer can be difficult since the cancer is not apparent on ultrasounds, [...]

Dr. Beth Overmoyer from Dana-Farber/Brigham and Women’s Cancer Center in Boston

By | August 11th, 2013|

In this video, Dr. Beth Overmoyer from Dana-Farber/Brigham and Women's Cancer Center in Boston outlines [...]

UK power!

By | July 30th, 2013|

I could just cry I am so moved... Recently some of the IBC sisters in [...]

International expert panel on IBC

By | June 18th, 2013|

Naoto Ueno MD PhD From Dr. Ueno, Excutive Director of the Morgan Welch [...]

“The Silence is Killing Me” – Inflammatory Breast Cancer Online Education and Advocacy Efforts to Bridge Patients and Researchers

By | June 12th, 2013|

  About 10,000 people attend the SABBC yearly. We have submitted an abstract [...]

Inflammatory Breast Cancer Support group in the New England Region

By | June 10th, 2013|

IBC support group You could imagine our excitement when one of our IBC [...]

ASCO & Triple Negative Breast Cancer

By | June 3rd, 2013|

Differential pathological complete response rates after neoadjuvant chemotherapy among molecular subtypes of triple negative breast [...]

Congratulations to Dr. Wendy Woodward!

By | May 31st, 2013|

Dr Wendy Woodward We are delighted to share that a first ever Inflammatory [...]

The Double Take – Dr. Ricardo Alvarez

By | May 16th, 2013|

Terry Arnold & Dr. Ricardo Alvarez I used to wonder if doctors at [...]

Congratulations to Dr. Hiroko Masuda!

By | May 15th, 2013|

Dr Hiroko Masuda. This happy picture is when she (on the right) attended a [...]

Clinical Trial – We will do this again!

By | May 14th, 2013|

Thank you letter from Dr. DePinho, President of MD Anderson We wanted you [...]

A Day in the Lab with an IBC Researcher

By | May 9th, 2013|

Dr. Angela Alexander invited me to shadow her for a full day in the IBC [...]

Funding Research Statin Trial

By | May 1st, 2013|

The funding of the statin trial at MDA with Dr. Woodward, Reuben, Uneo and [...]

IBC Webinar held at MD Anderson

By | May 1st, 2013|

from left to right, Dr. Ueno, me, Danielle Walsh, IBC program admin, Dr. Woodward, [...]

Order Please! The crucial difference that getting IBC treatments in order makes.

By | March 21st, 2013|

Tiny vent warning.... A few weeks ago I placed a shorter version of this post [...]

F.D.A. Approves a New Drug for Advanced Breast Cancer

By | February 21st, 2013|

Kadcyla but was known as T-DM1 is called the "New Herceptin" giving hope to [...]

Morgan Welch Inflammatory Breast Cancer

By | December 23rd, 2012|

Inflammatory Breast Cancer Research Program Inflammatory breast cancer is a rare form of breast cancer [...]

Statins – Inflammatory Breast Cancer

By | December 7th, 2012|

Over 10,000 breast cancer doctors attend the yearly San Antonio Breast Cancer Symposium [...]

Professional Oncology Education with Naoto Ueno, MD

By | December 3rd, 2012|

Naoto Ueno, MD., is Professor and Executive Director of Morgan Welch Inflammatory Breast Cancer Research [...]

ABC of TeamOncology (VIDEO)

By | November 27th, 2012|

Speaker Naoto T. Ueno, MD, PhD, FACP Professor of Medicine Executive Director of the Morgan [...]

Triple-Negative Breast Cancer Associated With Higher Risk of Local Recurrence

By | November 5th, 2012|

Since 27% of women with IBC are also Triple Negative, our site will include Triple [...]

Targeted Radiation for Breast Cancer May Cause More Complications

By | October 24th, 2012|

Study found brachytherapy had higher rates of wound, skin problems than whole-breast treatment in older [...]

The Other Side of the Ribbon

By | September 24th, 2012|

The other side of the ribbon... On this date, five years ago, I [...]

TNIBC Reacts to Moon Shots Program(Video)

By | September 24th, 2012|

At the Moon Shots press conference the film crew asked for comments. Please share. It [...]

IBC Map of the World

By | September 12th, 2012|

The IBC map is a personal project of Terry Arnold. We hope you view, share [...]

Frequently Asked Questions (FAQs)

By | August 29th, 2012|

About the Disease [qa cat="About the Disease"] Doctors and Specialists [qa cat="Doctors and Specialists"] Support [...]

Inflammatory Breast Cancer 101

By | August 26th, 2012|

This is a radio interview of Naoto T Ueno, MD, PhD by Terry Arnold. Dr. [...]

IBC: Breast Cancer Without a Lump

By | August 26th, 2012|

Reading about IBC can be difficult, the following articles will be graphic.   However, education on [...]

Clinical Trial Check Presentation to MD Anderson

By | August 24th, 2012|

Funding IBC's first Clinical Trial - Check Presentation to MD Anderson - April 2012

Recognizing and Treating Inflammatory Breast Cancer

By | July 30th, 2012|

This document is on loan to us from Dr. Wendy Woodward, and we thank her [...]

Networking Education for Breast Specialists

By | July 28th, 2012|

Medical Webinar, by invitation only.    Naoto Ueno MD PhD We are very grateful [...]

Load More Posts